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Background: Snoring disorder is a common problem among world population. Treatment modalities may involve 
surgical and non-surgical procedures. As main objective we proposed to evaluate the efficacy of non-ablative Er:-
YAG laser in the treatment of snoring disorder. 
Material and Methods: We performed an interventional study in 30 patients with snoring disorders. Three ses-
sions were performed with Er:YAG laser 2940nm in long pulse mode (2J/cm2) and smooth mode (10-8J/cm2) in 
oropharynx region. We analyzed the efficacy of this protocol using questionnaires for snoring intensity, snoring 
related characteristics of quality of life (including the Epworth sleepness scale and OHIP-14), the satisfaction of 
the patients and existence of adverse effects comparing the results before and after the treatment using Wilcoxon 
Signed Rank test.
Results: There was a 96.7% satisfaction rate after one month of treatment, and 96.4% after 6 months. A reduction 
of the severity of snoring from 8±1.9 before the treatment to 1.6±1.1 one month after treatment was observed 
(p<0.001). Decrease in mean values of Epworth sleepness scale (9.97±5.3 to 6.54±4.3) (p=0.002), and OHIP-14 
score (10.9±6.2 to 5.9±5) (p<0.001) were also noted. A significant decrease in the Mallampatti and Friedman 
classification scores were observed (p=0.001 and p<0.001, respectively). No anesthesia was required, nor adverse 
effects were observed.
Conclusion: Non-ablative Er:YAG laser treatment is a safe, painless, and can be an effective treatment option to redu-
ce snoring and is well accepted by the patient. However, further controlled studies with longer follow-up are required.




Snoring is a common social problem worldwide, with 
studies indicating that 45% of people often snore, more 
often in man and elderly people (1-3). Snoring sound 
could result from the vibration of the oropharynx tissues 
when there is a partial collapse of the upper airways, 
specially of soft palate, lateral walls of the pharynx, and 
the base of the tongue (2). 
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Snoring disorder may be implicated with health pro-
blems such as sleep deprivation, headaches, irritability, 
decreased concentration and sexual libido, social inte-
rrelation capacity, and obstructive sleep apnea (OSA). 
Some studies also indicate a positive relationship be-
tween a high snoring and the risk of stroke and even dea-
th. Moreover, snoring is considered a problem and often 
causes marital problems, and may even lead the couple 
to sleep in separate rooms commonly (1-5).
Several risk factors contribute to this condition such as 
obesity, alcoholism, consumption of sedatives, smoking, 
old age, anatomical variations that causes airway obs-
truction including long soft palate and also uvula with 
a longer length, hormonal problems, low tonus of the 
muscles of the throat or tongue, and hypertrophy of ton-
sils (1-3).
The diagnosis of snoring is based on a detailed clinical 
history and examination, and using adjuvant exams such 
as polysomnography (6,7). The presence of patient´s 
companion or couple member is important, since symp-
toms such as snoring or the presence of small awake-
nings are often not noticed by patient himself.
The treatment modalities for this disorder may involve 
surgical and non-surgical procedures. The first inter-
vention is related with the elimination of alcohol, smo-
king habits and promotion of exercise and controlled 
diet (1,3). Then, several options include mandibular 
advancement devices, or even positive pressure device 
(CPAP), here in cases of snoring associated to obstruc-
tive sleep apnea syndrome (OSAS) (1,3). Surgical and 
highly invasive procedures such as uvulopalatopharyn-
goplasty (UPPP) and laser uvulopalatoplasty are someti-
mes indicated (LAUP) (1-3,7,8). However, most of the-
se procedures have several limitations, such as possible 
low success rates or unpredictable results and noncom-
pliance of therapy by patients (6,8-10). 
Recently, an non-invasive treatment using Er:YAG laser 
in a non-ablative mode has been reported with the aim 
of the remodelling and new formation of collagen fibers 
leading to shortening of the mucosa and an increase of 
the oropharynx space facilitating the airflow passage (1-
3,11). This could be an alternative to existing treatments 
for the treatment of snoring and OSAS. However, the 
impact of this treatment including in several parame-
ters of the quality of life of these patients is scarce. We 
hypothesize that the treatment of snoring disorder with 
non-ablative Er:YAG laser protocol is capable of decrea-
se the intensity of snoring without significant complica-
tions. In the view of this, our aim is to evaluate the effec-
tiveness of a non-ablative Er:YAG laser protocol in the 
treatment of snoring disorder evaluating several snoring 
related characteristics of quality of life, the satisfaction 
of the patients with the treatment and existence of adver-
se effects or complications comparing the results before 
and after the treatment. 
Material and Methods
-Study population
This was an interventional prospective study with a co-
hort of patients with snoring disorder attending at the 
University Clinic of the Nova Saúde SA – University 
Institute of Health Sciences (IUCS), Oporto, Portugal 
between day 1 of January 2018 to 31 of December of 
2018. The study was performed in accordance with the 
Declaration of Helsinki and after the permission of the 
institutional ethical board of the University (IUCS Ethi-
cal Council) (16-CE-IUCS/2018). Patients attending to 
the University Clinic of the Nova Saúde SA because 
snoring were initially observed and then were send to a 
sleep disorder specialist appointment to perform a com-
plete clinical examination of nose and throat (including 
video/endoscopy, computed tomography and polysom-
nography). The inclusion criteria for the study were pa-
tients with diagnosis of snoring disorder, either sex, aged 
18 year-old or more. Exclusion criteria included patients 
younger than 18 years, pregnant women, patients with 
cardiac problems, with diagnosis of central apneas or 
larynx obstruction, patients taking photosensitive drugs, 
patients with alcohol habits misuse, patients already sur-
gically treated or with other treatments in course (inclu-
ding oral appliance - MAD), patients who were not able 
to perform the 3 sessions or follow-up appointments and 
non-cooperating patients. After applying the inclusion 
and exclusion criteria, of the initially 35 eligible pa-
tients, 5 were excluded (2 patients had performed other 
treatments before, and 3 were excluded by sleep specia-
list because two having central apnea and other patient 
with no confirmation of snoring disorder) (Fig. 1). The 
final sample was composed by 30 patients, 22 females 
and 8 males, with a mean age of 41.8±12.8, median age 
42 (range 18 to 65 years-old). 
-Laser Procedure
The treatment Laser procedure were performed in the 
Oral Laser Unit of the University Clinic of the Nova 
Saúde SA (IUCS), Oporto, Portugal. The patients were 
all treated in three sessions (at 1, 14 and 28 days) with 
a 2940 nm wavelength Er:YAG laser (Lightwalker AT-
S, Fotona®, Slovenia) with a non-contact irradiation of 
connective and muscles tissue of oropharynx (soft pa-
late including uvula, anterior and posterior pillar´s, and 
rest of oropharynx) using a PS04 handpiece with 7-mm 
spot size. The parameters were set as a combination of 
a long pulse (LP) with a fluence of 2J/cm2 with 12Hz 
in a brushing technique with 6 passes in a well-defined 
overlays and a smooth mode with a fluence of 10-8J/cm2 
with 2Hz performing 4-6 smooth pulses with 6 passes, 
with an overlap around 50%, with total pulses ranging 
between 10,000 and 12,000 pulses per session. Usual sa-
fety precautions related with the instrument for protec-
ting the operator, patient, and assistant were followed. 
At the end of each session the patient was asked the level 
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Fig. 1: Flow-chart of the included patients. The recruitment and di-
agnosis of patients started at day 1 of January and stop at the first of 
June of 2018. The treatment was performed between 1 March to 31 
of June and the 31 of July corresponded to last day for eventual one-
month follow-up period. Additionally, some variables were evalu-
ated by telephone interview after 6 months of the treatment having 
31 of December as last day.
of pain (VAS 0-5) and a photograph of the patient’s oral 
cavity was also taken.
-Outcome measures
Several clinical data including clinical history and phy-
sical examination, were recorded before and after the 
laser procedure in order to evaluate the efficacy of this 
protocol. During physical examination the patients were 
classified according to Mallampati anatomical classifi-
cation (visibility of tonsils, uvula and soft palate), Fried-
man Tongue classification (FTP) and also according 
body mass index (BMI) (12,13). Patients whose body 
mass index was between 25 Kg/m2 and 29.9 Kg/m2 were 
considered overweight and 30 Kg/m2 or more indicated 
obesity (13). 
Additionally, 3 questionnaires were performed. The 
snoring general questionnaire according to Miracki & 
Vizintin (cited in Storchi et al.) (2) was carried out and 
consisting of eight questions, assessing the severity of 
snoring (the first question) and other problems asso-
ciated with sleep-disordered breathing (questions 2-8). 
Answers were graded on 11-point scales (0-10) and two 
scores were taken as the main outcome measure: the 
snoring severity alone (Q1) and the total questionnaire 
(SGQ) score. The opinion of the respective spouses or 
persons who shared home with the patients were taken 
into consideration for the evaluation of the patient’s im-
provement helping the patient in his own perception of 
snoring. Possible adverse effects in the post-treatment 
period before and after each treatment session were also 
recorded. Additional questionnaires were performed in-
cluding the Epworth Sleepiness Scale (ESS) (ranging 0 
to 24 points) (13) and a quality of life for oral health 
related problems OHIP-14 (15), a questionnaire with 
14 questions (ranging 0 to 70 points). We considered 
the evaluation before the treatments and in a follow-up 
period after one month the treatments for all outcome 
variables by clinical examination and also 6 months 
after treatment for general questionnaire including the 
satisfaction of the patients (no satisfied or satisfied) by 
telephone interview.
We also used the mobile phone application Snorelab®, 
an audio-recording application for patients who snore, 
in order to obtain a chart recording the patient’s snoring 
intensity. Patients would have had to perform the appli-
cation the night before the first treatment and the night 
after they performed each laser session and then in the 
follow-up period of one month after.
-Statistical analysis
The data analysis was obtained by descriptive and in-
ferential statistics, using the SPSS-24.0 software (Sta-
tistical Package for Social Sciences). The results were 
expressed in absolute and relative frequencies. Non-pa-
rametric tests were used to analyze possible relations be-
tween variables (Wilcoxon matched-pairs signed ranks 
test, and McNemar test). Differences were considered 
statistically significant at P<0.05.
Results
Of the initial 35 patients observed referring snoring and 
after applying the inclusion and exclusion criteria, a total 
of 30 patients were included and evaluated in the study 
(Fig. 1). Of these, 22 (73.3%) were male and 8 (26.7%) 
were female. The ages of patients range from 18 years to 
65 years-old, with a median age of 42 years-old. The me-
dian body mass index (BMI) corresponded to 28.2 Kg/m2 
(mean of 27.4±4.7) where 8 (26.7%) patients had BMI 
less than 25 considered as normal, while 11 (36.7%) were 
overweight and 11 (36.7%) were obese. Less than 27% of 
the patients were smokers and 80% had alcoholic habits 
(only regular drinking without misuse drinking). Accor-
ding to Mallampati classification, 8 (26.7%) patients were 
class IV, 12 (40%) class III, 9 (30%) class II and only one 
(3.3%) was class I. Other clinical and demographic varia-
bles are reported in Table 1.
All patients included in the study performed the 3 laser 
sessions. All patients evaluated the pain/discomfort ex-
perienced during treatment (0-5). After the first session 
the mean pain was 0.47 points (range 0-1), after the se-
cond session was 0.37 (range 0-1) and at the last session 
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Table 1: Patient ś characteristics included in the study.
S.D. – standard deviation; * data not available in ten cases
corresponded to 0.37 (range 0-1). There was no need to 
use any type of anesthesia in any case. Each session had 
an approximated duration of 30 minutes.
In reevaluation after one month, a decrease in the Epwor-
th sleepiness scale, in the snoring intensity VAS as well 
as in several aspects of the quality of life of the patient 
was verified (Table 2). The severity of snoring was eva-
luated through the VAS scale (Table 2; Fig. 2), which 
showed reduction in the initial mean value of 8.03±1.9 
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Table 2: Patient ś characteristics related with snoring before and af-
ter the treatment.
S.D. – standard deviation; SGQ - general questionnaire score; OHIP-
14 – oral health impact profile-14.
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Fig. 2: Snoring VAS (snoring intensity own perception) reported before the treatment and after 
each treatment (TT) session and 1 month after.
lue of 1.7±1.1 after one month of treatment (p<0.001), 
which corresponds to a decrease of 78.8%. Dry mou-
th sensation upon waking decreased shortly after laser 
treatment as well as difficulty in waking up in the mor-
ning and the sensation of being tired during the day have 
also been reduced (p<0.001). When we use the SGQ 
questionnaire, again a significant reduction was obser-
ved in each session and specially after one month the 
end of the treatment from the initial value of 26.3±11.2 
to a final value of 2.9±2.5 (p<0.001) (Table 2), which 
corresponds to a decrease of 89%. We performed also 
an oral questionnaire related with oral mouth quality of 
life and we observed a reduction from an initial value 
of 10.9±6.2 to a value of 5.9±5 at the end of treatment 
(p<0.001).
With Snorelab® software, a reduction of 22% in the sno-
ring percentage was achieved shortly after the first ses-
sion (Snorelab® median values of 52% before treatment 
to 30% after the first treatment) and 20% one month af-
ter the end of the 3rd session (Snorelab® values from 
52% to 32%) (p<0.001). 
Regarding the evaluation of anatomical position of ton-
gue and palate thought Mallampati and Friedman tongue 
position classification we observed a significant decrease 
in the levels of both scores as we can observe in Table 2. 
We also assessed the patient satisfaction of the treatment 
after one month and 96.7% of the patients were satisfied 
with the results. At this time 14 (46.7%) patients answe-
red that they maintained a stable result of the effect of 
the treatment, 1 (3.3%) stated a partial loss of effect and 
15 (50%) affirmed an improvement in the result. No pa-
tient reported adverse effects at one-month follow-up. 
Two patients were lost to follow-up at 6 months. The re-
maining 28 patients were interviewed by telephone and 
we obtained 96.4% of patient satisfaction, a maintaining 
or improvement of the effect of the treatment was repor-
ted by 92.9% of patients and a mean snoring VAS of 1.9. 
We performed a sub-analysis regarding age, BMI, Ma-
llampati and Friedman classification and didn´t find sta-
tistical differences in the evaluated outcome variables 
between these subgroups.
Discussion
Snoring is a problem with a strong impact on social and 
specially marital relationships, and can be also an indi-
cator of diseases with risk for the life (1-5). Currently, 
many treatments can be performed, but many of them 
are too invasive, with significant adverse effects, with 
need of general anesthesia and many times with high re-
currences rates (7-10). New non-invasive methods for 
this condition, as main treatment or in combination with 
other existent options are needed in order to improve 
the patients’ quality of life. Our aim in this work was to 
evaluate the effectiveness and safeness of a non-abla-
tive Er:YAG laser protocol in the treatment of snoring 
disorder. 
We observed an improvement of snoring VAS score in 
78.8% (8.03 to 1.7) of the patients at one month after the 
treatments. This result is in line with the other studies 
with a final overall improvement range of 65% to 85% 
(2). We observe an improvement of 45% immediately 
after the first session, 61% after the second session, and 
69% after the third session. Storchi et al. (2) observed a 
70% of VAS score reduction after the three treatments. 
Additionally, to the improvements in the snoring reduc-
tion, we observed an improvement in sleep quality and 
other quality of life variables. We observed a decreased 
in the general SGQ questionnaire of 89% after one month 
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of follow-up but also in specific in score variables such 
as “Tired during the day”, “Difficulty to wake up” and 
other variables assessed by the SGQ questionnaire. We 
performed also the OHIP-14 questionnaire (15), com-
monly used for the evaluation of oral health problems. 
We observe that patients were feel better of oral health 
conditions after treatment. This is an important result as 
oral cavity could be affected by symptoms related with 
snoring disorders. 
We introduce a mobile phone application Snorelab® in 
order to obtain a chart with the record of the patient’s 
snoring intensity. We have confirmed a significant re-
duction of the snoring intensity, shortly after the first 
session and also at the follow-up of one month. This is 
an important result as represent a more objective and 
easily measure of the daily snoring intensity for the pa-
tients. Nevertheless, some information about the use of 
this software must be given to the patients to prevent 
some bias that could occur during the utilization this 
software. The same conditions before and after the treat-
ment monitoring must be critically followed. This appli-
cation could be also important allowing an increase in 
the awareness of the condition for the patients and could 
be used in a routine daily base.   
When we analyse Mallampati and Friedman classifica-
tions at one month after the treatment a significant de-
crease in scores were noted which could suggest that an 
increase in oropharynx airspace was obtained for the-
se patients. We acknowledged that these classifications 
could be subjective and affected by several conditions, 
but other studies have shown an increase in oropharynx 
airflow after non-ablative Er:YAG laser procedure in hu-
man and lab studies (11,22). Lee and Lee (11) in a pilot 
study with 7 patients using cone beam computed tomo-
graphy reported an increase in the mean total airway vo-
lume 12 weeks post-laser treatment. This effect could be 
a result, initially, of shrinking of collagen fibers of trea-
ted area and then of the formation of new collagen fibers 
resulting in a remodeling of oropharynx space (16-21). 
The shrinkage of collagen tissue was also demonstrated 
in a histologic study of the soft palate of 20 rats submit-
ted to a non-surgical Er:YAG laser procedure (22).
No relevant complications were present and the treat-
ments were well accepted by the patients.  There was no 
need for anesthesia and all treatments were performed 
in all patients as reported by others (1). This suggest the 
safeness of this Er:YAG laser protocol that is in line with 
other reports (1-3,11).
Almost all patients were satisfied with the obtained re-
sults of the treatment and many of them had an impro-
vement in their result at one month of follow-up. This 
could be related with the collagen remodeling that could 
be expected in a period of few months after treatment 
(16,20). Patients were interviewed by telephone after 6 
months the end of the treatment and the rate of satisfac-
tion was maintained the same confirming that this is an 
efficient protocol after even 6 months of the end of last 
session. 
We could not find differences in the results regarding 
age, gender, BMI, Mallampatti or Friedman classifi-
cation. Although, this need further investigation with 
studies with bigger samples and long follow-up time to 
confirm this, our results suggest that this treatment can 
be used in several patients regarding age or BMI cha-
racteristics. In fact, some of highest reduction in snoring 
index were observed in obese patients. 
We acknowledge some limitations or potential bias of 
the presented study, such as the limited number of pa-
tients included in the sample or the short follow-up time 
of evaluation. Unfortunately, in some cases, we had a 
limited access to the complete polysomnography’s data 
performed by patient´s and specially after treatment 
as observed in other studies (2). However, all patients 
included in this study were diagnosed with snoring di-
sorder by specialist in sleep disorders (performing the 
adjuvant exams necessary for diagnosis) and have given 
authorization for inclusion in our treatment protocol. 
Moreover, we have evaluated several variables related 
to snoring such as Epworth Sleepiness Scale (ESS), 
Mallampati anatomical classification, Friedman Tongue 
classification and also a more objective tool, the mobi-
le phone application Snorelab®. To our knowledge this 
is the first report of a series of selected cases reporting 
a significant decrease in intensity of snoring confirmed 
by Snorelab® software with an increase in the quality 
of life related with oral health measure by the OHIP-14 
score.
As conclusion, our results showed that non-ablative Er:-
YAG laser protocol used here is a safe, painless non-in-
vasive and effective treatment option to reduce snoring 
and is well accepted by the patient. Interestingly, an 
improve in the quality of life related with mouth health 
and snoring characteristics was also demonstrated with 
results observed shortly after the first treatment. Further 
studies are required with longer follow-up, and especia-
lly with control arm group.
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